Tag: Ravulizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ravulizumab

AstraZeneca Ultomiris gets approval in EU to treat rare neuromuscular disorder

Added to Collection on: 2022-09-23 08:34:27

Tags for this article:

Organ systems
Branches of biology
Nervous system
Quaternary ammonium compounds
RTT
GMG
Neuromuscular junction
Acetylcholine receptor
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Acetylcholine
Myasthenia gravis
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis - Morningstar

Added to Collection on: 2022-09-23 07:58:10

Tags for this article:

Autoimmune diseases
Organ systems
Monoclonal antibodies
Myasthenia gravis
RTT
Quaternary ammonium compounds
Drugs
Companies
Myasthenia
AstraZeneca
Ravulizumab
Acetylcholine
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

Added to Collection on: 2024-04-15 20:56:51

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Autoimmune diseases
Eculizumab
Myasthenia gravis
Rare diseases
Ravulizumab
Apheresis
Atypical hemolytic uremic syndrome

Click the tags to see associated articles and topics

View Article Details
Safety Considerations for Ravulizumab in NMOSD: Sean Pittock, MD - NeurologyLive

Added to Collection on: 2024-04-23 19:08:11

Tags for this article:

Monoclonal antibodies
Orphan drugs
Autoimmune diseases
Rare diseases
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Multiple sclerosis
Aquaporin-4
Ravulizumab
Therapy

Click the tags to see associated articles and topics

View Article Details
Ravulizumab Outperforms NMOSD Therapies in Preventing Relapse, Meta-Analysis Reveals

Added to Collection on: 2024-05-14 19:11:40

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Inebilizumab
Satralizumab
Eculizumab
Multiple sclerosis
Ravulizumab
Relapse prevention
Aquaporin-4

Click the tags to see associated articles and topics

View Article Details
Reviewing Ravulizumab's Long-Term Profile as New NMOSD Treatment - NeurologyLive

Added to Collection on: 2024-05-18 19:10:46

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Ravulizumab
Multiple sclerosis
Horizon Therapeutics
Genentech

Click the tags to see associated articles and topics

View Article Details
FDA clears Amgen's Bkemv as first biosimilar of Soliris - Pharmaphorum

Added to Collection on: 2024-05-29 21:48:08

Tags for this article:

Orphan drugs
Monoclonal antibodies
Acquired hemolytic anemia
Immunosuppressants
Eculizumab
Hemolytic–uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Amgen
Alexion Pharmaceuticals
United States
Soliris

Click the tags to see associated articles and topics

View Article Details
Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults ... - Placera

Added to Collection on: 2024-07-23 17:05:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Rare diseases
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Alexion Pharmaceuticals
Danicopan
Hemolytic anemia
Hemolysis
Soliris

Click the tags to see associated articles and topics

View Article Details
NICE recommendation for new Alexion PNH treatment - PharmaTimes

Added to Collection on: 2024-10-24 15:34:41

Tags for this article:

Orphan drugs
Monoclonal antibodies
Immunosuppressants
Rare diseases
Complement system
Ravulizumab
Paroxysmal nocturnal hemoglobinuria
Eculizumab
Hemolysis
Hemolytic anemia
Factor D
AstraZeneca
Alexion

Click the tags to see associated articles and topics

View Article Details
Iptacopan Is a Cost-Effective Therapy in Improving Quality of Life in PNH

Added to Collection on: 2025-02-21 20:21:55

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Health care quality
Paroxysmal nocturnal hemoglobinuria
Quality-adjusted life year
Iptacopan
Eculizumab
Ravulizumab
Danicopan

Click the tags to see associated articles and topics

View Article Details